Vol 2011, No 6 (2011)

Table of Contents

Research & Development

Heptares Therapeutics and AstraZeneca to Research GPCR Drug Targets Abstract
Heather Cartwright

Licensing

AVEO Licenses Early-Stage RON-Targeted Antibodies to Centocor Ortho Biotech Abstract
Heather Cartwright
Vertex Enhances its HCV Pipeline by Licensing Alios BioPharma’s Nucleotide Analogues Abstract
Heather Cartwright
Boehringer Ingelheim Licenses Zealand Pharma’s Drug Candidates for Type 2 Diabetes and Obesity Abstract
Heather Cartwright
Abbott to Develop and Commercialise Biotest’s BT-061 for Autoimmune Diseases Abstract
Heather Cartwright
Merck & Co. and Hanwha Chemical Partner to Develop a Biosimilar Version of Enbrel® Abstract
Heather Cartwright

Mergers & Acquisitions

Shire to Enter Regenerative Medicine Market with Advanced BioHealing Acquisition Abstract
Heather Cartwright
Valeant Continues its Expansion in Central and Eastern Europe with Sanitas Acquisition Abstract
Heather Cartwright
Watson Increases its European Presence with US$563 M Specifar Acquisition Abstract
Heather Cartwright

Distribution & Marketing

Merck & Co. Joins Forces with Roche for Promotion of Victrelis™ Abstract
Heather Cartwright


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.